Scinai Immunotherapeutics Ltd. (SCNI) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Sales/Revenue | 487.67K | 386.5K | 386.5K | 206K | 168K | 284K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | 26.18% | 36.09% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 1.6M | 1.02M | 1.02M | 373K | 417K | 448K | 157.73K | 84.91K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 328.63% | 264.3% | 264.3% | 181.07% | 248.21% | 157.75% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -1.11M | -635K | -635K | -167K | -249K | -164K | -157.73K | -84.91K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | -228.63% | -164.29% | -164.29% | -81.07% | -148.21% | -57.75% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | -75.59% | -287.2% | -302.59% | -96.68% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 1.35M | 1.25M | 1.25M | 2.1M | 2.17M | -4.12M | 2.05M | 1.82M | 2.1M | -8.97M | 3.19M | -4.32M | -1.08M | 3.26M | 2.62M | -7.68M | 2.55M | 2.73M | 2.02M | 3.77M |
| OpEx % of Revenue | 275.87% | 322.51% | 322.51% | 1017.48% | 1292.26% | -1450.35% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 719.04K | 628K | 497.4K | 759K | 764K | 519K | 484K | 1.13M | 968K | 1.14M | 1.19M | 1.81M | 937.21K | 1.29M | 1.45M | 2.09M | 1.92M | 2.15M | 1.2M | 1.33M |
| SG&A % of Revenue | 147.44% | 162.48% | 128.69% | 368.45% | 454.76% | 182.75% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 626.3K | 618.5K | 1.29M | 1.34M | 1.41M | 1.22M | 1.57M | 627K | 1.13M | 1.45M | 2M | 1.74M | 1.12M | 1.97M | 1.37M | 1.1M | 627.77K | 582.73K | 822.42K | 2.45M |
| R&D % of Revenue | 128.43% | 160.03% | 333.51% | 649.03% | 837.5% | 428.17% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | -539.9K | 0 | 0 | -1000K | 0 | 63K | 0 | -1000K | 0 | -1000K | -1000K | 0 | -209K | -1000K | 0 | 0 | 0 | 312 |
| Operating Income | -2.46M | -1.88M | -1.88M | -2.26M | -2.42M | 3.96M | -2.05M | -1.82M | -2.1M | 8.97M | -3.19M | 4.32M | 1.08M | -3.26M | -2.62M | 7.68M | -2.55M | -2.73M | -2.02M | -3.77M |
| Operating Margin % | -504.5% | -486.8% | -486.8% | -1098.54% | -1440.48% | 1392.61% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -30.76% | -147.57% | 8.31% | -24.14% | -15.13% | -55.89% | 35.59% | -142.17% | -293.91% | 374.81% | -21.84% | -43.7% | 142.49% | -19.52% | -29.46% | 303.42% | 56.15% | 41.2% | 64.25% | 59.98% |
| EBITDA | -2.01M | -1.53M | -1.53M | -1.76M | -1.92M | 4.45M | -1.9M | -1.74M | -1.96M | 9.11M | -3.05M | 4.46M | 1.3M | -3.12M | -2.48M | 7.87M | -2.36M | -2.54M | -1.84M | -3.59M |
| EBITDA Margin % | -411.86% | -395.73% | -395.73% | -856.31% | -1144.05% | 1567.25% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -31.32% | -134.36% | 19.33% | -1.44% | 1.79% | -51.15% | 37.8% | -138.96% | -250.29% | 392.25% | -22.85% | -43.27% | 155.15% | -22.52% | -35.19% | 318.95% | 58.1% | 43.06% | 66.52% | 61.7% |
| D&A (Non-Cash Add-back) | 451.77K | 352K | 352K | 499K | 498K | 496K | 156K | 84K | 145K | 145.33K | 138K | 140.5K | 218.18K | 145K | 134K | 188.32K | 189.82K | 185.16K | 184.84K | 181.85K |
| EBIT | -2.46M | -1.88M | -1.19M | -2.17M | 12.34M | -2.03M | -1.93M | -1.82M | -2.1M | -2.6M | -3.19M | -6.74M | 1.08M | -3.26M | -2.62M | -3.18M | -2.55M | -2.73M | -2.02M | -3.77M |
| Net Interest Income | -111.7K | -185.5K | 10.94K | -37K | 12.88M | -295K | -231K | -512.5K | 5.21M | -1.15M | -325.92K | 4M | 6.88M | 280K | 140K | 60.55K | -255K | -837.19K | -428K | -231.97K |
| Interest Income | 0 | 0 | 10.94K | 0 | 14.76M | 0 | 2.56K | 0 | 5.19M | 0 | 0 | 4M | 6.88M | 469.03K | 378.94K | 923.84K | 612.26K | 0 | 370.35K | 0 |
| Interest Expense | 111.7K | 185.5K | 10.94K | 37K | 1.88M | 293.92K | 233.56K | 512.5K | 0 | 1.15M | 325.92K | 0 | 0 | 189.03K | 238.94K | 863.29K | 866.13K | 837.19K | 798.31K | 231.97K |
| Other Income/Expense | 6.03M | -185.5K | -185.5K | 33K | 12.88M | -6.28M | -107K | -507K | 5.21M | -12.73M | -329K | -4.85M | -33.65K | 280K | 140K | -6.49M | -255K | -948K | -428K | -611K |
| Pretax Income | 3.57M | -2.07M | -2.07M | -2.23M | 10.46M | -2.32M | -2.16M | -2.33M | 3.11M | -3.76M | -3.52M | -529K | 1.05M | -2.98M | -2.48M | 1.19M | -2.81M | -3.68M | -2.45M | -4.39M |
| Pretax Margin % | 731.49% | -534.8% | -534.8% | -1082.52% | 6223.21% | -817.61% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 3.57M | -2.07M | -2.07M | -2.23M | 10.46M | -2.32M | -2.16M | -2.33M | 3.11M | -3.76M | -3.52M | -529K | 1.05M | -2.98M | -2.48M | 1.19M | -2.81M | -3.68M | -2.45M | -4.39M |
| Net Margin % | 731.49% | -534.8% | -534.8% | -1082.52% | 6223.21% | -817.61% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 272.58% | 10.98% | 4.26% | 4.29% | 236.5% | 38.28% | 38.58% | -340.45% | 195.62% | -26.11% | -42.02% | -144.45% | 137.46% | 18.9% | -1.1% | 127.13% | -117.38% | 69.64% | -134.93% | 64.79% |
| Net Income (Continuing) | 3.57M | -2.07M | -2.07M | -2.23M | 10.46M | -2.32M | -2.16M | -2.33M | 3.11M | -3.76M | -3.52M | -529K | 1.05M | -2.98M | -2.48M | 1.19M | -2.81M | -3.68M | -2.45M | -4.39M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 3840.00 | -1.20 | -1.20 | -8.80 | 12.40 | -3.60 | -4.40 | -10.40 | 26480.00 | -44520.00 | -48000.00 | -46800.00 | 22520.00 | -63920.00 | -53160.00 | -63440.00 | -99240.00 | -102680.00 | -73800.00 | -155600.00 |
| EPS Growth % | 320100% | 66.67% | 72.73% | 15.38% | -99.95% | 99.99% | 99.99% | 99.98% | 17.58% | 30.35% | 9.71% | 26.23% | 122.69% | 37.75% | 27.97% | 59.23% | -121.25% | 77.04% | -80.88% | 66.1% |
| EPS (Basic) | 3840.00 | -1.20 | -1.20 | -8.80 | 12.40 | -3.60 | -4.40 | -7.60 | 26480.00 | -44520.00 | -43400.00 | -10880.00 | 22520.00 | -63920.00 | -53160.00 | 32800.00 | -78320.00 | -102680.00 | -73800.00 | -152240.00 |
| Diluted Shares Outstanding | 946 | 1.59M | 806.37K | 806.37K | 843.57K | 637.6K | 506.54K | 300.38K | 469.22K | 337.96K | 323.81K | 194.35K | 186.79K | 186.72K | 186.18K | 145.15K | 143.3K | 143.3K | 132.71K | 115.22K |
| Basic Shares Outstanding | 946 | 1.59M | 806.37K | 806.37K | 843.57K | 637.6K | 506.54K | 223.32K | 469.22K | 337.96K | 292.92K | 194.35K | 186.79K | 186.72K | 186.18K | 75.06K | 113.07K | 143.3K | 132.71K | 112.76K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |